Site Map

About Us

• About BioTherapeutics
• About Baxter
• BioScience Global Facilities

Therapeutic Areas

• EU Overview
• Immunoglobulins
• Critical Care

Patient Commitment

• BT Overview
• Immunoglobulin Therapies
• Primary Immunodeficiencies (PID) Commitment
• ITP Commitment

Research & Development

• Overview
• Development Pipeline
• Core Strengths
• Researcher Profiles & Interviews

BioLife Plasma Services

• Who we are
• From Donor to Patient
• Facility Information

Quality & Safety

• Business Unification
• Plasma Fractionation Expertise
• Global Pharmacovigilance / Post Marketing Surveillance
• Global Product and Distribution Surveillance
• Regulatory / Industry Adherence

Resources

• Immunoglobulin Resources
• General Resources
• Congress & Events